NSE BSE
panacea biotec ltd stock

PANACEA BIOTEC LTD Share Price

- - (%)
- NSE: PANACEABIO

PANACEA BIOTEC LTD Share Price Update

As of the latest trading session, PANACEA BIOTEC LTD share price is currently at 137.3, which is down by -2.12 from its previous closing. Today, the stock has fluctuated between 137.00 and 142.29. Over the past year, PANACEA BIOTEC LTD has achieved a return of 11.45 %. In the last month alone, the return has been 4.11 %. Read More...

PANACEA BIOTEC LTD Performance

Day Range

Low137.00 High142.29
137.47

52 Week Range

Low 112.35 High 202.50
137.47

PANACEA BIOTEC LTD Share Price

4055

531349

PANACEABIO

img img img img
No Data Available

Open Price

140.78

Prev. Close

139.43

Volume (Shares)

162552.00

Total traded value

223.46

Upper Circuit

167.31

Lower Circuit

111.54

Note: The current prices & values are delayed, Login to your account for live updates.

PANACEA BIOTEC LTD Fundamentals


(Standalone)

Market Cap (Cr) 840.97
PE Ratio (TTM) 240.69
Book Value / Share 53.73
Beta 1.01
ROE 0.00%
EPS (TTM) 0.58
Dividend Yield 0.00%
Net Profit Qtr (Cr) -1.37

PANACEA BIOTEC LTD Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars MAR 2024 (Values in Cr)
Revenue 80.37
Operating Expense 98.11
Net Profit -1.37
Net Profit Margin (%) -1.70
Earnings Per Share (EPS) -0.22
EBITDA 7.14
Effective Tax Rate (%) -1.48
Particulars DEC 2023 (Values in Cr)
Revenue 95.23
Operating Expense 97.21
Net Profit 0.43
Net Profit Margin (%) 0.45
Earnings Per Share (EPS) 0.07
EBITDA 9.69
Effective Tax Rate (%) 59.81
Particulars SEP 2023 (Values in Cr)
Revenue 94.59
Operating Expense 93.52
Net Profit 3.20
Net Profit Margin (%) 3.38
Earnings Per Share (EPS) 0.52
EBITDA 12.09
Effective Tax Rate (%) 0.00
Particulars JUN 2023 (Values in Cr)
Revenue 89.41
Operating Expense 91.46
Net Profit 1.29
Net Profit Margin (%) 1.44
Earnings Per Share (EPS) 0.21
EBITDA 10.15
Effective Tax Rate (%) 0.00
Particulars MAR 2023 (Values in Cr)
Revenue 75.02
Operating Expense 80.19
Net Profit -19.69
Net Profit Margin (%) -26.24
Earnings Per Share (EPS) -3.21
EBITDA 13.70
Effective Tax Rate (%) 486.07
Particulars MAR 2024 (Values in Cr)
Revenue 359.60
Operating Expense 380.29
Net Profit 3.55
Net Profit Margin (%) 0.98
Earnings Per Share (EPS) 0.58
EBITDA 39.08
Effective Tax Rate (%) 15.67
Particulars MAR 2023 (Values in Cr)
Revenue 257.07
Operating Expense 354.25
Net Profit -87.54
Net Profit Margin (%) -34.05
Earnings Per Share (EPS) -14.29
EBITDA -28.18
Effective Tax Rate (%) -39.50
Particulars MAR 2022 (Values in Cr)
Revenue 235.50
Operating Expense 341.65
Net Profit -93.58
Net Profit Margin (%) -39.73
Earnings Per Share (EPS) -15.28
EBITDA -60.10
Effective Tax Rate (%) 0.00
Particulars MAR 2021 (Values in Cr)
Revenue 343.56
Operating Expense 377.15
Net Profit -14.44
Net Profit Margin (%) -4.20
Earnings Per Share (EPS) -2.35
EBITDA 21.24
Effective Tax Rate (%) -12.14
Particulars MAR 2020 (Values in Cr)
Revenue 158.09
Operating Expense 252.49
Net Profit -153.08
Net Profit Margin (%) -96.83
Earnings Per Share (EPS) -24.99
EBITDA -46.75
Effective Tax Rate (%) -21.66
Particulars MAR 2023 (Values in Cr)
Book Value / Share 134.20
ROE % -11.06
ROCE % -9.51
Total Debt to Total Equity 0.03
EBITDA Margin -11.22
Particulars MAR 2022 (Values in Cr)
Book Value / Share 139.59
ROE % -60.80
ROCE % -5.11
Total Debt to Total Equity 1.32
EBITDA Margin -0.34
Particulars MAR 2021 (Values in Cr)
Book Value / Share -40.87
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin 13.64
Particulars MAR 2020 (Values in Cr)
Book Value / Share 23.67
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 2.53
EBITDA Margin 15.44
Particulars MAR 2019 (Values in Cr)
Book Value / Share 55.63
ROE % -87.43
ROCE % -15.79
Total Debt to Total Equity 2.41
EBITDA Margin -28.31
Particulars MAR 2023 (Values in Cr)
Book Value / Share 49.63
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.25
EBITDA Margin -10.97
Particulars MAR 2022 (Values in Cr)
Book Value / Share 64.24
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.16
EBITDA Margin -25.52
Particulars MAR 2021 (Values in Cr)
Book Value / Share 79.43
ROE % -2.53
ROCE % -1.10
Total Debt to Total Equity 0.09
EBITDA Margin 5.22
Particulars MAR 2020 (Values in Cr)
Book Value / Share 136.97
ROE % -18.56
ROCE % -8.22
Total Debt to Total Equity 0.58
EBITDA Margin -37.58
Particulars MAR 2019 (Values in Cr)
Book Value / Share 66.75
ROE % -68.49
ROCE % -13.68
Total Debt to Total Equity 2.02
EBITDA Margin -144.02
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 225.99
Total Assets 1271.16
Total Liabilities 1271.16
Total Equity 840.11
Share Outstanding 61250746
Price to Book Ratio 2.18
Return on Assets (%) -2.61
Return on Capital (%) -3.86
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 583.27
Total Assets 1758.86
Total Liabilities 1758.86
Total Equity 873.65
Share Outstanding 61250746
Price to Book Ratio 2.31
Return on Assets (%) 61.30
Return on Capital (%) 118.78
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 135.79
Total Assets 1177.53
Total Liabilities 1177.53
Total Equity -231.69
Share Outstanding 61250750
Price to Book Ratio 2.23
Return on Assets (%) -12.54
Return on Capital (%) -25.13
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 89.75
Total Assets 1390.30
Total Liabilities 1390.30
Total Equity 195.74
Share Outstanding 61250750
Price to Book Ratio 0.80
Return on Assets (%) -13.97
Return on Capital (%) -23.91
Particulars MAR 2019 (Values in Cr)
Cash & Short Term Investments 23.48
Total Assets 1375.52
Total Liabilities 1375.52
Total Equity 347.38
Share Outstanding 61250750
Price to Book Ratio 2.97
Return on Assets (%) 2.74
Return on Capital (%) 8.15
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 43.25
Total Assets 723.90
Total Liabilities 723.90
Total Equity 325.65
Share Outstanding 61250746
Price to Book Ratio 2.18
Return on Assets (%) -12.09
Return on Capital (%) -20.45
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 42.68
Total Assets 761.83
Total Liabilities 761.83
Total Equity 415.09
Share Outstanding 61250746
Price to Book Ratio 2.31
Return on Assets (%) -12.28
Return on Capital (%) -18.74
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 88.96
Total Assets 790.28
Total Liabilities 790.28
Total Equity 508.16
Share Outstanding 61250750
Price to Book Ratio 2.23
Return on Assets (%) -1.82
Return on Capital (%) -2.52
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 60.60
Total Assets 1138.48
Total Liabilities 1138.48
Total Equity 892.73
Share Outstanding 61250750
Price to Book Ratio 0.80
Return on Assets (%) -13.44
Return on Capital (%) -16
Particulars MAR 2019 (Values in Cr)
Cash & Short Term Investments 7.85
Total Assets 1442.03
Total Liabilities 1442.03
Total Equity 418.47
Share Outstanding 61250750
Price to Book Ratio 2.97
Return on Assets (%) 1.84
Return on Capital (%) 4.61
Particulars MAR 2023 (Values in Cr)
Net Income 12.80
Cash from Operations -419.97
Cash from Investing 430.33
Cash from Financing -18.37
Net change in Cash -10.49
Free Cash Flow -379.02
Particulars MAR 2022 (Values in Cr)
Net Income 1449.35
Cash from Operations 295.25
Cash from Investing 1282.57
Cash from Financing -1175.85
Net change in Cash -1.72
Free Cash Flow 307.76
Particulars MAR 2021 (Values in Cr)
Net Income -145.03
Cash from Operations 107.75
Cash from Investing -47.67
Cash from Financing -47.11
Net change in Cash 11.97
Free Cash Flow 129.52
Particulars MAR 2020 (Values in Cr)
Net Income -177.34
Cash from Operations -21.79
Cash from Investing -34.76
Cash from Financing 90.73
Net change in Cash 25.50
Free Cash Flow -14.88
Particulars MAR 2019 (Values in Cr)
Net Income 46.22
Cash from Operations 102.96
Cash from Investing -5.27
Cash from Financing -101.14
Net change in Cash -1.61
Free Cash Flow 107.75
Particulars MAR 2023 (Values in Cr)
Net Income -62.75
Cash from Operations -9.65
Cash from Investing 2.41
Cash from Financing 9.00
Net change in Cash 0.67
Free Cash Flow 28.72
Particulars MAR 2022 (Values in Cr)
Net Income -93.57
Cash from Operations -51.86
Cash from Investing 39.54
Cash from Financing 9.82
Net change in Cash -3.32
Free Cash Flow -43.81
Particulars MAR 2021 (Values in Cr)
Net Income -12.88
Cash from Operations 39.24
Cash from Investing -37.32
Cash from Financing -7.20
Net change in Cash -6.25
Free Cash Flow 53.78
Particulars MAR 2020 (Values in Cr)
Net Income -135.97
Cash from Operations -74.95
Cash from Investing -18.51
Cash from Financing 109.39
Net change in Cash 8.02
Free Cash Flow -72.63
Particulars MAR 2019 (Values in Cr)
Net Income 37.17
Cash from Operations 106.73
Cash from Investing -8.33
Cash from Financing -98.45
Net change in Cash 0.37
Free Cash Flow 111.40
Company Name Price P/E P/B Market Cap 52 Week Low/High
PANACEA BIOTEC LTD 139.60 0.00 1.01 855.06 112.70 / 202.20
BLISS GVS PHARMA LTD 115.55 12.63 1.25 1210.24 77.65 / 148.95
CIPLA LTD 1511.95 28.67 4.57 122092.68 1018.30 / 1581.70
FERMENTA BIOTECH LIMITED 198.30 0.00 2.01 583.62 136.60 / 219.05
GLAXOSMITHKLINE PHARMA LT 2570.85 66.33 24.49 43551.75 1376.50 / 2759.00
Company Name Price P/E P/B Market Cap 52 Week Low/High
PANACEA BIOTEC LTD 139.60 240.69 2.59 855.06 112.70 / 202.20
AMRUTAJAN HEALTH LTD 751.75 48.31 7.53 2173.36 556.05 / 826.00
ASTRAZENECA PHARMA IND LT 6756.05 112.98 23.72 16890.13 3715.05 / 7550.00
BLISS GVS PHARMA LTD 115.55 15.89 1.22 1210.24 77.65 / 148.95
ABBOTT INDIA LIMITED 27481.60 48.62 15.78 58398.40 21907.45 / 29628.15

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 140.00
  • 26 Days 135.40
  • 10 Days 138.90
  • 50 Days 136.30
  • 12 Days 139.10
  • 100 Days 138.70
  • 20 Days 137.30
  • 200 Days 154.60
140.15
PIVOT
First Resistance 142.28
Second Resistance 145.14
Third Resistance 147.27
First Support 137.29
Second Support 135.16
Third Support 132.30
RSI 57.54
MACD 3.69
Commodity Channel Index (CCI) 71.01
ADX 64.86
Williams % R -53.22

Over 1 Month

down

4.11

Over 3 Months

down

-3.30

Over 6 Months

down

-25.85

Over 1 Year

down

11.45

Over 3 Years

down

-28.07

Over 5 Years

down

0.24

PANACEA BIOTEC LTD Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

PANACEA BIOTEC LTD Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Others
26.13
Promoter Holdings
73.58
FII
0.27
DII
0.0
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Dr. Rajesh Jain Shareholding of Promoter and Promoter Group 3.0217312E7 49.33
Mr. Sandeep Jain Shareholding of Promoter and Promoter Group 1.00316E7 16.38
Mrs. Nirmala Jain Shareholding of Promoter and Promoter Group 2511000.0 4.1
First Lucre Partnership Co. Shareholding of Promoter and Promoter Group 2255815.0 3.68
Second Lucre Partnership Co. Shareholding of Promoter and Promoter Group 57639.0 0.09
Mr. Ashish Jain Shareholding of Promoter and Promoter Group 500.0 0.0
Mr. Abhey Kumar Jain Shareholding of Promoter and Promoter Group 0.0 0.0
Sandeep Jain (huf) (karta : Sandeep Jain) Shareholding of Promoter and Promoter Group 0.0 0.0
Rajesh Jain (huf) (karta : Rajesh Jain) Shareholding of Promoter and Promoter Group 0.0 0.0
Mrs. Priyanka Jain Shareholding of Promoter and Promoter Group 0.0 0.0
Mr. Harshet Jain Shareholding of Promoter and Promoter Group 0.0 0.0
Mr. Ankesh Jain Shareholding of Promoter and Promoter Group 0.0 0.0
Mrs. Radhika Jain Shareholding of Promoter and Promoter Group 0.0 0.0
Mr. Sumit Jain Shareholding of Promoter and Promoter Group 0.0 0.0
Mrs. Pamilla Jain Shareholding of Promoter and Promoter Group 0.0 0.0
Mrs. Meena Jain Shareholding of Promoter and Promoter Group 0.0 0.0
Mrs. Sunanda Jain Shareholding of Promoter and Promoter Group 0.0 0.0

PANACEA BIOTEC LTD

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
2011-09-19 0.75 Final 2011-09-21 Equity shares 2010-09-16 0.25 Final 2010-09-20 Equity shares 2008-09-19 1.0 Final 2008-09-23 Equity shares 2007-09-21 1.0 Final 2007-09-25 Equity shares 2005-08-12 0.0 Final 2005-08-17 Equity shares
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date
2003-02-03 10.0 1.0 2003-02-11

Learn More About Stocks

About PANACEA BIOTEC LTD

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by PANACEA BIOTEC LTD

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 5x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Panacea Biotec Ltd?

Answer Field

The share price of Panacea Biotec Ltd for NSE is ₹ 137.3 and for BSE is ₹ 137.75.

What is the Market Cap of Panacea Biotec Ltd?

Answer Field

The market cap of Panacea Biotec Ltd for NSE is ₹ 840.97 Cr. and for BSE is ₹ 843.72 Cr. as of now.

What is the 52 Week High and Low of Panacea Biotec Ltd?

Answer Field

The 52 Week High and Low of Panacea Biotec Ltd for NSE is ₹ 202.50 and ₹ 112.35 and for BSE is ₹ 202.20 and ₹ 112.70.

How to Buy Panacea Biotec Ltd share?

Answer Field

You can trade in Panacea Biotec Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Panacea Biotec Ltd?

Answer Field

The 1 year returns on the stock has been 11.45%.

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

7.5 Lacs+ Users

icon-with-text

4.3+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4300 Cr MTF Book

icon-with-text
loader